Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial.

David Z I CherneyBernard CharbonnelFrancesco CosentinoSamuel Dagogo-JackDarren K McGuireRichard PratleyWeichung J ShihRobert FrederichMario MaldonadoAnnpey PongChristopher P Cannonnull null

Published in: Diabetologia (2021)

ClinicalTrials.gov NCT01986881.

Keyphrases

clinical trial
study protocol
open label
phase iii
phase ii
double blind
placebo controlled
randomized controlled trial
metabolic syndrome
type diabetes